Review



anti rap80  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals anti rap80
    Anti Rap80, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/pmc11363320__pnas__2320804121__sapp-9-18-29
    Average 93 stars, based on 1 article reviews
    anti rap80 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Ubiquitin Proteomics:

    Article Title: Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice.
    Article Snippet: L3MBTL1 (TRCN0000016867) and nontargeting shRNA constructs were obtained from Sigma-Aldrich. .. Antibodies We used the following antibodies: Flag (F3165, Sigma-Aldrich), DDDDK-tag (PM020, MBL), Myc (sc-40, Santa Cruz Biotechnology), conjugated ubiquitin (302-06751 [FK2], Nippon Biotest Laboratories), 53BP1 (NB100-305, Novus Biologicals; 612523 [19], BD Biosciences), RAP80 (NBP1-87156, Novus), RPA32 (NA18, Calbiochem) and RAD51 (70-001 lot 1, Bio Academia). ..

    Article Title: MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
    Article Snippet: .. 53BP1 (Santa Cruz, sc22760; IF, 1:1,000); Conjugated ubiquitin (FK2; Enzo Life Sciences, BML-PW8800; IF, 1:10,000); RAP80 (Novus Biologicals, NBP1-87156; IF, 1:300); γ-H2AX (Millipore, 05–636, IF, 1:1000; WB, 1:500); Flag (WAKO, 018–22381; WB, 1:5000, Medical & Biological Laboratories Co., Ltd. (MBL), PM020; WB, 1:2000, IP, 1:200, M185-3L (FLA-1); IF and PLA, 1:5000); MDC1 (Abcam, ab11171; IF and PLA, 1:2,000, WB, 1:5000, IP, 1:300,); EHMT1 (MBL, D220-3; WB, 1:1000); EHMT2 (Cell signaling, 3306; WB, 1:500); histone H3 (Abcam, ab1791; WB: 1:5,000); H3K9me2 (Abcam, ab1220; WB: 1:1,000); HA (MBL, 561; WB, 1:2000, IP, 1:500); ATM (Santa Cruz, sc23921; WB, 1:200); MRE11 (Abcam, ab214; WB 1:500); NBS1 (GeneTex, GTX70224; WB 1:2000); H2A (Millipore, 07–146; WB, 1:1000); phospholyrated ATM (Ser1981) (Abcam, ab81292; WB, 1:5000, Cell signaling, 4526; IF and PLA, 1:500); TRF1 (GeneTex, GTX10579; PLA, 1:200). ..

    Western Blot:

    Article Title: The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection
    Article Snippet: .. Antibodies—Antibodies were used at the following dilutions: RPA2 9H8 (Novus NB600-565), 1:500 (IF, WB); 53BP1 (Novus NB100-904), 1:500 (IF); CENPF (Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) 22791), 1:200 (IF); Rad51 (Santa Cruz Biotechnology, Inc. 8349), 1:100 (IF); H2AX (Upstate JBW301), 1:2000 (IF); CtIP (Santa Cruz Biotechnology, Inc. 5970), 1:100 (IF) and 1:200 (WB); RAP80 (in house) 1:500 (IF, WB); Mre11 (Novus), 1:200 (IF); CtIP (Abcam 70163), 1:500 (WB); pRPA Ser4/Ser8 (Bethyl A300-245A), 1:1000 (WB). siRNA Sequences—siRNA sequences were as follows: luciferase, 5 -gccauucuauccucuagaggaug; RAP80-1, 5 -ccaguuggagguuuaucaa; RAP80-2, 5 -uuugucuccgagucaauac; BRCC36, 5 - aacaucaacaugugaaggc; 53BP1, 5 -uauuaccgucuccucguuc; CtIP, 5 -acacacucauggugauaaa; BRCA1, 5 -agauaguucuaccaguaaa; Abraxas, 5 -cguuuagagagaggcugcuucacaa. ..

    Article Title: MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
    Article Snippet: .. 53BP1 (Santa Cruz, sc22760; IF, 1:1,000); Conjugated ubiquitin (FK2; Enzo Life Sciences, BML-PW8800; IF, 1:10,000); RAP80 (Novus Biologicals, NBP1-87156; IF, 1:300); γ-H2AX (Millipore, 05–636, IF, 1:1000; WB, 1:500); Flag (WAKO, 018–22381; WB, 1:5000, Medical & Biological Laboratories Co., Ltd. (MBL), PM020; WB, 1:2000, IP, 1:200, M185-3L (FLA-1); IF and PLA, 1:5000); MDC1 (Abcam, ab11171; IF and PLA, 1:2,000, WB, 1:5000, IP, 1:300,); EHMT1 (MBL, D220-3; WB, 1:1000); EHMT2 (Cell signaling, 3306; WB, 1:500); histone H3 (Abcam, ab1791; WB: 1:5,000); H3K9me2 (Abcam, ab1220; WB: 1:1,000); HA (MBL, 561; WB, 1:2000, IP, 1:500); ATM (Santa Cruz, sc23921; WB, 1:200); MRE11 (Abcam, ab214; WB 1:500); NBS1 (GeneTex, GTX70224; WB 1:2000); H2A (Millipore, 07–146; WB, 1:1000); phospholyrated ATM (Ser1981) (Abcam, ab81292; WB, 1:5000, Cell signaling, 4526; IF and PLA, 1:500); TRF1 (GeneTex, GTX10579; PLA, 1:200). ..

    Luciferase:

    Article Title: The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection
    Article Snippet: .. Antibodies—Antibodies were used at the following dilutions: RPA2 9H8 (Novus NB600-565), 1:500 (IF, WB); 53BP1 (Novus NB100-904), 1:500 (IF); CENPF (Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) 22791), 1:200 (IF); Rad51 (Santa Cruz Biotechnology, Inc. 8349), 1:100 (IF); H2AX (Upstate JBW301), 1:2000 (IF); CtIP (Santa Cruz Biotechnology, Inc. 5970), 1:100 (IF) and 1:200 (WB); RAP80 (in house) 1:500 (IF, WB); Mre11 (Novus), 1:200 (IF); CtIP (Abcam 70163), 1:500 (WB); pRPA Ser4/Ser8 (Bethyl A300-245A), 1:1000 (WB). siRNA Sequences—siRNA sequences were as follows: luciferase, 5 -gccauucuauccucuagaggaug; RAP80-1, 5 -ccaguuggagguuuaucaa; RAP80-2, 5 -uuugucuccgagucaauac; BRCC36, 5 - aacaucaacaugugaaggc; 53BP1, 5 -uauuaccgucuccucguuc; CtIP, 5 -acacacucauggugauaaa; BRCA1, 5 -agauaguucuaccaguaaa; Abraxas, 5 -cguuuagagagaggcugcuucacaa. ..

    Proximity Ligation Assay:

    Article Title: MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
    Article Snippet: .. 53BP1 (Santa Cruz, sc22760; IF, 1:1,000); Conjugated ubiquitin (FK2; Enzo Life Sciences, BML-PW8800; IF, 1:10,000); RAP80 (Novus Biologicals, NBP1-87156; IF, 1:300); γ-H2AX (Millipore, 05–636, IF, 1:1000; WB, 1:500); Flag (WAKO, 018–22381; WB, 1:5000, Medical & Biological Laboratories Co., Ltd. (MBL), PM020; WB, 1:2000, IP, 1:200, M185-3L (FLA-1); IF and PLA, 1:5000); MDC1 (Abcam, ab11171; IF and PLA, 1:2,000, WB, 1:5000, IP, 1:300,); EHMT1 (MBL, D220-3; WB, 1:1000); EHMT2 (Cell signaling, 3306; WB, 1:500); histone H3 (Abcam, ab1791; WB: 1:5,000); H3K9me2 (Abcam, ab1220; WB: 1:1,000); HA (MBL, 561; WB, 1:2000, IP, 1:500); ATM (Santa Cruz, sc23921; WB, 1:200); MRE11 (Abcam, ab214; WB 1:500); NBS1 (GeneTex, GTX70224; WB 1:2000); H2A (Millipore, 07–146; WB, 1:1000); phospholyrated ATM (Ser1981) (Abcam, ab81292; WB, 1:5000, Cell signaling, 4526; IF and PLA, 1:500); TRF1 (GeneTex, GTX10579; PLA, 1:200). ..



    Similar Products

    93
    Bio-Techne corporation rap80 antibody
    Rap80 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/custom%40nbp1-87156%4040054443
    Average 93 stars, based on 1 article reviews
    rap80 antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    88
    Addgene inc poz n fh rap80
    (a and b), Representative immunofluorescence images of <t>RAP80</t> foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.
    Poz N Fh Rap80, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/pOZ-N-FH+RAP80+(Plasmid+%2327501)/bio_rxiv__64898__2026__03__20__713277-240-16-18
    Average 88 stars, based on 1 article reviews
    poz n fh rap80 - by Bioz Stars, 2026-11
    88/100 stars
      Buy from Supplier

    93
    Fortis Life Sciences rabbit anti rap80
    (a and b), Representative immunofluorescence images of <t>RAP80</t> foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.
    Rabbit Anti Rap80, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/bio_rxiv__64898__2026__03__20__713105-224-16-20
    Average 93 stars, based on 1 article reviews
    rabbit anti rap80 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Bethyl anti rap80
    (a and b), Representative immunofluorescence images of <t>RAP80</t> foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.
    Anti Rap80, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/pmc11363320__pnas__2320804121__sapp-9-18-20
    Average 93 stars, based on 1 article reviews
    anti rap80 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals anti rap80
    (a and b), Representative immunofluorescence images of <t>RAP80</t> foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.
    Anti Rap80, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/pmc11363320__pnas__2320804121__sapp-9-18-29
    Average 93 stars, based on 1 article reviews
    anti rap80 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    ABclonal Biotechnology anti rap80
    a. Endogenous <t>RAP80</t> expression profiles across various post-HSV-1 infection stages were evaluated in HeLa cells exposed to HSV-1 at a multiplicity of infection (MOI) = 1. Cells were harvested at different time points post-infection, and RAP80 and ICP0 protein levels examined by immunoblotting with specific antibodies. b. Representative immunofluorescence images showing cellular RAP80 colocalization with the viral proteins ICP0, ICP4, and ICP8 in HeLa cells. Images were captured at 3 h post-infection with HSV-1 (MOI=1). Quantified RAP80 (red) and viral protein (green) fluorescence intensity values at colocalization sites were determined using ImageJ software. c. RAP80 knockdown (KD) effects on viral TK expression were assessed in HeLa cells with depleted RAP80 at 3 h or 20 h post-infection with HSV-1 (MOI=1). d. Specific RAP80 binding sites in the HSV-1 genome were investigated by ChIP-seq using ChIP DNA extracted from HeLa cells with a RAP80 antibody at 3 h post HSV-1 infection (MOI=1). Specific HSV-1 genomic regions, where ChIP-sequencing peaks aligned, are shown in a comprehensive plot. e. 3D-SIM was used to visualize RAP80 colocalization (red) with ICP4 (green) in HeLa cells infected with HSV-1 (MOI=1) for 3 h. f. RAP80 KD effects on RNA polymerase II recruitment to viral gene promoters were evaluated in HeLa cells by ChIP assays using the RNA polymerase II S2P antibody. g. Representative immunofluorescence images showing ICP4 in WT and RAP80 KD HeLa cells following infection with HSV-1 (MOI=1) for 3 h (left). ICP4 droplet diameters were measured in Imariz software (right). The graph represents data from three independent experiments and counts represent 50–100 infected cells. h, i . Immunofluorescence images showing RAP80 -depleted HeLa cells re-expressing WT RAP80 or its mutant ( 2AS or 3KR ), which were infected with HSV-1 (MOI=1) for 3 h. Cells were stained with DAPI and ICP4 and RAP80-specific antibodies. (h) ICP4 droplet diameters and colocalization between different RAP80 and ICP4 forms were measured (i). j. RAP80 effects on TK expression were evaluated in RAP80 -depleted HeLa cells plus reintroduced WT RAP80 or mutants ( 2AS or 3KR ). Cells were infected with HSV-1 (MOI=1) for 3 h and qRT-PCR assays performed to examine TK expression. k. RNA polymerase II recruitment to viral gene promoters was assessed in HeLa cells expressing WT RAP80 or mutants ( 2AS or 3KR ) in ChIP assays using a specific RNA polymerase II S2P antibody. l. The model shows multivalent interactions between RAP80 and ICP4 in phase separation formation (viral pre-replication foci). After HSV-1 infection, RAP80 binds to the viral transcription factor ICP4 and the viral genome through its UIM domain, driving phase separation formation. Data in panels c, f, g, i-k are presented as the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.
    Anti Rap80, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/UIMC1+Rabbit+pAb/bio_rxiv__2025__06__10__658793-207-22-24
    Average 93 stars, based on 1 article reviews
    anti rap80 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Proteintech rap80
    PKMYT1-induced NPM1 S260 phosphorylation promotes efficient DSB repair. a Western blot analysis of the expression of PKMYT1, phosphorylated-NPM1 S260, and phosphorylated-NPM1 T199 in OS cells after being treated with various concentrations of DDP. b – d Western blot analysis of the effect of DDP and IR on NPM1 S260 phosphorylation after PKMYT1 knockdown or inhibition with RP6306. e Western blot analysis of the impact of DDP and IR on NPM1 S260 phosphorylation following the overexpression of NPM1 S260 dephosphorylation mutant plasmid. f After transfection as indicated siRNAs for 48 h, HEK293T cells were collected and subjected to co-immunoprecipitation experiments followed by western blot analysis. g HEK293T cells were transfected with indicated siRNAs for 48 h and treated with or without cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. h HEK293T cells were treated with or without RP6306 (2 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. i HEK293T cells were treated with or without RP6306 (2 μM) and cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. j HEK293T cells were transfected with indicated plasmids for 24 h and treated with or without cisplatin (1 μM) before harvesting the cells for co-immunoprecipitation and Western blot. k – l Immunofluorescence analysis of the effect of NPM1 S260 phosphorylation on IR-induced BRCA1 foci. NPM1 knockout U2OS cells were rescued with either wild-type NPM1, NPM1 S260A mutant and NPM1 S260D mutant, with or without IR (10 Gy) treatment. Representative images are shown in k , and the number of BRCA1 foci per group was calculated in l. Approximately 100 cells were counted per group. Data are expressed as the mean ± SEM from three biological replicates. Statistical analysis was performed using Student’s t test, p value as indicated. Scale bar, 10 μm. m – n Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in m, and the number of BRCA1 foci per group was calculated in n, p value as indicated. Scale bar, 10 μm. o – p NPM1 knockout U2OS cells were rescued with indicated plasmids for 24 h, and immunofluorescence analysis of cells exposed to 10 Gy IR and recovered for 1 h. Representative immunofluorescence images were shown in o , and the number of RAD51 foci per group was shown in p , p value as indicated. Scale bar, 10 μm. q – r Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( q ), and the number of RAD51 foci per group was calculated in r . Scale bar, 10 μm. s , t Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( s ), and the number of <t>RAP80</t> foci per group was calculated in t , p value as indicated. Scale bar, 10 μm. u HR assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with BRCA1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts. P value as indicated. v NHEJ assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with 53BP1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts, p value as indicated
    Rap80, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/UIMC1+Antibody/pmc12092789-302-50-52
    Average 93 stars, based on 1 article reviews
    rap80 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals hpa017384
    PKMYT1-induced NPM1 S260 phosphorylation promotes efficient DSB repair. a Western blot analysis of the expression of PKMYT1, phosphorylated-NPM1 S260, and phosphorylated-NPM1 T199 in OS cells after being treated with various concentrations of DDP. b – d Western blot analysis of the effect of DDP and IR on NPM1 S260 phosphorylation after PKMYT1 knockdown or inhibition with RP6306. e Western blot analysis of the impact of DDP and IR on NPM1 S260 phosphorylation following the overexpression of NPM1 S260 dephosphorylation mutant plasmid. f After transfection as indicated siRNAs for 48 h, HEK293T cells were collected and subjected to co-immunoprecipitation experiments followed by western blot analysis. g HEK293T cells were transfected with indicated siRNAs for 48 h and treated with or without cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. h HEK293T cells were treated with or without RP6306 (2 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. i HEK293T cells were treated with or without RP6306 (2 μM) and cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. j HEK293T cells were transfected with indicated plasmids for 24 h and treated with or without cisplatin (1 μM) before harvesting the cells for co-immunoprecipitation and Western blot. k – l Immunofluorescence analysis of the effect of NPM1 S260 phosphorylation on IR-induced BRCA1 foci. NPM1 knockout U2OS cells were rescued with either wild-type NPM1, NPM1 S260A mutant and NPM1 S260D mutant, with or without IR (10 Gy) treatment. Representative images are shown in k , and the number of BRCA1 foci per group was calculated in l. Approximately 100 cells were counted per group. Data are expressed as the mean ± SEM from three biological replicates. Statistical analysis was performed using Student’s t test, p value as indicated. Scale bar, 10 μm. m – n Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in m, and the number of BRCA1 foci per group was calculated in n, p value as indicated. Scale bar, 10 μm. o – p NPM1 knockout U2OS cells were rescued with indicated plasmids for 24 h, and immunofluorescence analysis of cells exposed to 10 Gy IR and recovered for 1 h. Representative immunofluorescence images were shown in o , and the number of RAD51 foci per group was shown in p , p value as indicated. Scale bar, 10 μm. q – r Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( q ), and the number of RAD51 foci per group was calculated in r . Scale bar, 10 μm. s , t Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( s ), and the number of <t>RAP80</t> foci per group was calculated in t , p value as indicated. Scale bar, 10 μm. u HR assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with BRCA1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts. P value as indicated. v NHEJ assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with 53BP1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts, p value as indicated
    Hpa017384, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/RAP80+Antibody/pm40054443-333-200-205
    Average 93 stars, based on 1 article reviews
    hpa017384 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    GenScript corporation pcdna5/frt/to myc rap80 sim sir
    PKMYT1-induced NPM1 S260 phosphorylation promotes efficient DSB repair. a Western blot analysis of the expression of PKMYT1, phosphorylated-NPM1 S260, and phosphorylated-NPM1 T199 in OS cells after being treated with various concentrations of DDP. b – d Western blot analysis of the effect of DDP and IR on NPM1 S260 phosphorylation after PKMYT1 knockdown or inhibition with RP6306. e Western blot analysis of the impact of DDP and IR on NPM1 S260 phosphorylation following the overexpression of NPM1 S260 dephosphorylation mutant plasmid. f After transfection as indicated siRNAs for 48 h, HEK293T cells were collected and subjected to co-immunoprecipitation experiments followed by western blot analysis. g HEK293T cells were transfected with indicated siRNAs for 48 h and treated with or without cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. h HEK293T cells were treated with or without RP6306 (2 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. i HEK293T cells were treated with or without RP6306 (2 μM) and cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. j HEK293T cells were transfected with indicated plasmids for 24 h and treated with or without cisplatin (1 μM) before harvesting the cells for co-immunoprecipitation and Western blot. k – l Immunofluorescence analysis of the effect of NPM1 S260 phosphorylation on IR-induced BRCA1 foci. NPM1 knockout U2OS cells were rescued with either wild-type NPM1, NPM1 S260A mutant and NPM1 S260D mutant, with or without IR (10 Gy) treatment. Representative images are shown in k , and the number of BRCA1 foci per group was calculated in l. Approximately 100 cells were counted per group. Data are expressed as the mean ± SEM from three biological replicates. Statistical analysis was performed using Student’s t test, p value as indicated. Scale bar, 10 μm. m – n Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in m, and the number of BRCA1 foci per group was calculated in n, p value as indicated. Scale bar, 10 μm. o – p NPM1 knockout U2OS cells were rescued with indicated plasmids for 24 h, and immunofluorescence analysis of cells exposed to 10 Gy IR and recovered for 1 h. Representative immunofluorescence images were shown in o , and the number of RAD51 foci per group was shown in p , p value as indicated. Scale bar, 10 μm. q – r Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( q ), and the number of RAD51 foci per group was calculated in r . Scale bar, 10 μm. s , t Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( s ), and the number of <t>RAP80</t> foci per group was calculated in t , p value as indicated. Scale bar, 10 μm. u HR assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with BRCA1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts. P value as indicated. v NHEJ assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with 53BP1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts, p value as indicated
    Pcdna5/Frt/To Myc Rap80 Sim Sir, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rap80/pcdna5+frt+to+dmelorco+template/pm40054443-344-235-239
    Average 90 stars, based on 1 article reviews
    pcdna5/frt/to myc rap80 sim sir - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    (a and b), Representative immunofluorescence images of RAP80 foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.

    Journal: bioRxiv

    Article Title: The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

    doi: 10.64898/2026.03.20.713277

    Figure Lengend Snippet: (a and b), Representative immunofluorescence images of RAP80 foci in HT-29 cells treated with CPT (1 µM) alone or in combination with ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( a ). Quantification of the RAP80 foci is shown ( b ). Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 325 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. c, Representative immunofluorescence images showing increased HA-ABRAXAS foci in HT-29 cells upon ATM inhibition. Cells were treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. γH2AX marks cells with CPT-induced replication damage. Scale bar is shown. d, Quantification of the data from experiments as described in (c). Experiments were repeated three times with similar results. Data are mean ± SEM derived from n ≥ 300 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. (e and f), Representative immunofluorescence images of BRCA1 foci in control (sgROSA) and ABRAXAS KO HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment ( e ). Scatter plot showing ABRAXAS-dependent increased BRCA1 foci in CPT-treated cells following ATM inhibition ( f ). Data represent mean ± SEM derived from n ≥ 145 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.

    Article Snippet: ABRAXAS and RAP80 mutants were generated by site-directed mutagenesis of pOZ-N-FH Abraxas (Addgene, Plasmid #27495) and pOZ-N-FH RAP80 (Addgene, Plasmid #27501) retrovirus expression plasmids, respectively using Q5 Site-Directed Mutagenesis kit (New England Biolabs, E0554S).

    Techniques: Immunofluorescence, Derivative Assay, Two Tailed Test, Inhibition, Control

    a , Schematic showing structural domains of RAP80. SIM, SUMO interaction motif; UIMs, Ubiquitin interaction motifs; AIR, ABRAXAS interacting region; ZnFs, Zinc finger domains. b , Western blots showing RAP80 protein levels in RAP80 KO HT-29 cells complemented with FLAG-HA tagged WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM RAP80. GAPDH serves as loading control. c, Scatter plot showing quantification of HA-RAP80 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. Data represent mean ± SEM derived from n ≥ 230 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. d, Scatter plot showing quantification of BRCA1 foci in the genotypes as indicated in (c). Data are mean ± SEM from n ≥ 280 cells examined over two repeats; p values are indicated, unpaired two-tailed t test. e, Quantification of RPA immunofluorescence in HT-29 cells expressing RAP80 WT or the indicated deletion mutants upon treatment with CPT (1 µM) + ATMi (250 nM) for 1 h. Data represent mean ± SEM derived from n ≥ 125 cells examined over two repeats; p values are indicated, unpaired two-tailed test. f, Line graph showing relative colony survival of control (sgROSA) and RAP80 KO HT-29 cells harboring empty vector (EV) or complemented with WT or RAP80 deletion mutants. Cells were treated with 100 nM ATMi and the indicated doses of CPT. p values were determined for differences in colony survival for RAP80 KO (EV), ΔSIM or ΔSIM + ΔUIM harboring cells over WT at CPT concentrations of 0.5 and 1 nM; unpaired two-tailed t test. Data represents mean ± SD from n =3 biological experiments. g, Scatter plot showing quantification of RAP80-EdU PLA in control (sgROSA), RNF8 or RNF168 KO HT-29 cells treated with 50 nM CPT +/- ATMi (250 nM). Cells were optionally pretreated with ATMi for 10 minutes followed by CPT treatment for 40 minutes. EdU was added during the last 20 min of CPT treatment. ATMi was present throughout the experiment. Data represent mean ± SEM derived from n ≥ 279 nuclei examined over two independent experiments; p values are indicated, unpaired two-tailed t test. h, Quantification of BRCA1-EdU PLA as described in (e). Data are mean ± SEM from n ≥ 239 nuclei pooled from two independent experiments; p values are indicated, unpaired two-tailed t test.

    Journal: bioRxiv

    Article Title: The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

    doi: 10.64898/2026.03.20.713277

    Figure Lengend Snippet: a , Schematic showing structural domains of RAP80. SIM, SUMO interaction motif; UIMs, Ubiquitin interaction motifs; AIR, ABRAXAS interacting region; ZnFs, Zinc finger domains. b , Western blots showing RAP80 protein levels in RAP80 KO HT-29 cells complemented with FLAG-HA tagged WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM RAP80. GAPDH serves as loading control. c, Scatter plot showing quantification of HA-RAP80 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. Data represent mean ± SEM derived from n ≥ 230 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. d, Scatter plot showing quantification of BRCA1 foci in the genotypes as indicated in (c). Data are mean ± SEM from n ≥ 280 cells examined over two repeats; p values are indicated, unpaired two-tailed t test. e, Quantification of RPA immunofluorescence in HT-29 cells expressing RAP80 WT or the indicated deletion mutants upon treatment with CPT (1 µM) + ATMi (250 nM) for 1 h. Data represent mean ± SEM derived from n ≥ 125 cells examined over two repeats; p values are indicated, unpaired two-tailed test. f, Line graph showing relative colony survival of control (sgROSA) and RAP80 KO HT-29 cells harboring empty vector (EV) or complemented with WT or RAP80 deletion mutants. Cells were treated with 100 nM ATMi and the indicated doses of CPT. p values were determined for differences in colony survival for RAP80 KO (EV), ΔSIM or ΔSIM + ΔUIM harboring cells over WT at CPT concentrations of 0.5 and 1 nM; unpaired two-tailed t test. Data represents mean ± SD from n =3 biological experiments. g, Scatter plot showing quantification of RAP80-EdU PLA in control (sgROSA), RNF8 or RNF168 KO HT-29 cells treated with 50 nM CPT +/- ATMi (250 nM). Cells were optionally pretreated with ATMi for 10 minutes followed by CPT treatment for 40 minutes. EdU was added during the last 20 min of CPT treatment. ATMi was present throughout the experiment. Data represent mean ± SEM derived from n ≥ 279 nuclei examined over two independent experiments; p values are indicated, unpaired two-tailed t test. h, Quantification of BRCA1-EdU PLA as described in (e). Data are mean ± SEM from n ≥ 239 nuclei pooled from two independent experiments; p values are indicated, unpaired two-tailed t test.

    Article Snippet: ABRAXAS and RAP80 mutants were generated by site-directed mutagenesis of pOZ-N-FH Abraxas (Addgene, Plasmid #27495) and pOZ-N-FH RAP80 (Addgene, Plasmid #27501) retrovirus expression plasmids, respectively using Q5 Site-Directed Mutagenesis kit (New England Biolabs, E0554S).

    Techniques: Ubiquitin Proteomics, Western Blot, Control, Expressing, Derivative Assay, Two Tailed Test, Immunofluorescence, Plasmid Preparation

    a, Representative immunofluorescence images of HA-RAP80 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. b, Representative BRCA1 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated as described in (a). (c, d) Inhibition of SUMOylation by the SUMO E1 inhibitor ML-792 reduces BRCA1-A damage localization in ATMi-treated cells. Representative images of RAP80-EdU PLA in HT-29 cells treated with 50 nM CPT+/- 250 nM ATMi. Cells were optionally treated with ML-792 (1 µM) for 16 h prior to CPT treatment (c). Quantification of RAP80-SIRF PLA foci is shown (d). Data represent mean ± SEM derived from n ≥ 545 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. e, Left panel: PLA-SIRF experiment showing increased SUMO2/3 abundance at CPT-damaged fork upon ATM inhibition. HT-29 cells were optionally pretreated with ATMi (250 nM) for 10 minutes followed by CPT (1 µM) treatment for 40 minutes. EdU was added during the last 20 min of CPT treatment. ATMi was present throughout the experiment. Right panel: Scatter plot showing quantification of SUMO2/3-EdU SIRF foci normalized to average EdU-EdU signal in each experimental condition. Experiments were performed three times with similar results. Data represent mean ± SEM derived from n ≥ 500 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. f, Left panel: PLA-SIRF experiment showing FK2-Ub accumulation at CPT-damaged fork upon ATM inhibition. HT-29 cells were treated as described in (e). Right panel: Quantification of the data is shown. Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 506 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.

    Journal: bioRxiv

    Article Title: The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

    doi: 10.64898/2026.03.20.713277

    Figure Lengend Snippet: a, Representative immunofluorescence images of HA-RAP80 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated with CPT (1 µM) +/- ATMi (250 nM) for 1 h. ATMi was added 10 min before CPT treatment. b, Representative BRCA1 foci in WT, ΔUIM, ΔSIM or ΔSIM + ΔUIM expressing HT-29 cells treated as described in (a). (c, d) Inhibition of SUMOylation by the SUMO E1 inhibitor ML-792 reduces BRCA1-A damage localization in ATMi-treated cells. Representative images of RAP80-EdU PLA in HT-29 cells treated with 50 nM CPT+/- 250 nM ATMi. Cells were optionally treated with ML-792 (1 µM) for 16 h prior to CPT treatment (c). Quantification of RAP80-SIRF PLA foci is shown (d). Data represent mean ± SEM derived from n ≥ 545 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. e, Left panel: PLA-SIRF experiment showing increased SUMO2/3 abundance at CPT-damaged fork upon ATM inhibition. HT-29 cells were optionally pretreated with ATMi (250 nM) for 10 minutes followed by CPT (1 µM) treatment for 40 minutes. EdU was added during the last 20 min of CPT treatment. ATMi was present throughout the experiment. Right panel: Scatter plot showing quantification of SUMO2/3-EdU SIRF foci normalized to average EdU-EdU signal in each experimental condition. Experiments were performed three times with similar results. Data represent mean ± SEM derived from n ≥ 500 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test. f, Left panel: PLA-SIRF experiment showing FK2-Ub accumulation at CPT-damaged fork upon ATM inhibition. HT-29 cells were treated as described in (e). Right panel: Quantification of the data is shown. Experiments were performed four times with similar results. Data represent mean ± SEM derived from n ≥ 506 cells examined over two independent experiments; p values are indicated, unpaired two-tailed t test.

    Article Snippet: ABRAXAS and RAP80 mutants were generated by site-directed mutagenesis of pOZ-N-FH Abraxas (Addgene, Plasmid #27495) and pOZ-N-FH RAP80 (Addgene, Plasmid #27501) retrovirus expression plasmids, respectively using Q5 Site-Directed Mutagenesis kit (New England Biolabs, E0554S).

    Techniques: Immunofluorescence, Expressing, Inhibition, Derivative Assay, Two Tailed Test

    a, Representative RPA immunofluorescence in control (sgROSA) and RAP80 KO HT-29 cells complemented with WT or RAP80 deletion mutants. Cells were pretreated with ATMi (250 nM) for 10 min followed by CPT (1 µM) treatment for 1 h. b, Representative colony images of control (sgROSA) or RAP80 KO HT-29 cells harboring empty vector (EV) or complemented with WT or RAP80 deletion mutants, Cells were treated with 100 nM ATMi in combination with the indicated doses of CPT.

    Journal: bioRxiv

    Article Title: The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

    doi: 10.64898/2026.03.20.713277

    Figure Lengend Snippet: a, Representative RPA immunofluorescence in control (sgROSA) and RAP80 KO HT-29 cells complemented with WT or RAP80 deletion mutants. Cells were pretreated with ATMi (250 nM) for 10 min followed by CPT (1 µM) treatment for 1 h. b, Representative colony images of control (sgROSA) or RAP80 KO HT-29 cells harboring empty vector (EV) or complemented with WT or RAP80 deletion mutants, Cells were treated with 100 nM ATMi in combination with the indicated doses of CPT.

    Article Snippet: ABRAXAS and RAP80 mutants were generated by site-directed mutagenesis of pOZ-N-FH Abraxas (Addgene, Plasmid #27495) and pOZ-N-FH RAP80 (Addgene, Plasmid #27501) retrovirus expression plasmids, respectively using Q5 Site-Directed Mutagenesis kit (New England Biolabs, E0554S).

    Techniques: Immunofluorescence, Control, Plasmid Preparation

    (a,b) Scatter plot showing CldU (a) and IdU (b) tract length determined from the fork restart experiments as described in . p -values were determined from n ≥ 135 DNA fibers using two-tailed Mann–Whitney test. Red bar indicates median tract length. c, Bar graph showing quantification of chromosomal aberrations in HT-29 cells expressing either WT or SIM+UIM deleted RAP80. Data represent mean ± SEM of n=3 repeats. At least 60 metaphase spreads were analyzed for each condition across three repeats; p values are indicated; unpaired two-tailed t test.

    Journal: bioRxiv

    Article Title: The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells

    doi: 10.64898/2026.03.20.713277

    Figure Lengend Snippet: (a,b) Scatter plot showing CldU (a) and IdU (b) tract length determined from the fork restart experiments as described in . p -values were determined from n ≥ 135 DNA fibers using two-tailed Mann–Whitney test. Red bar indicates median tract length. c, Bar graph showing quantification of chromosomal aberrations in HT-29 cells expressing either WT or SIM+UIM deleted RAP80. Data represent mean ± SEM of n=3 repeats. At least 60 metaphase spreads were analyzed for each condition across three repeats; p values are indicated; unpaired two-tailed t test.

    Article Snippet: ABRAXAS and RAP80 mutants were generated by site-directed mutagenesis of pOZ-N-FH Abraxas (Addgene, Plasmid #27495) and pOZ-N-FH RAP80 (Addgene, Plasmid #27501) retrovirus expression plasmids, respectively using Q5 Site-Directed Mutagenesis kit (New England Biolabs, E0554S).

    Techniques: Two Tailed Test, MANN-WHITNEY, Expressing

    a. Endogenous RAP80 expression profiles across various post-HSV-1 infection stages were evaluated in HeLa cells exposed to HSV-1 at a multiplicity of infection (MOI) = 1. Cells were harvested at different time points post-infection, and RAP80 and ICP0 protein levels examined by immunoblotting with specific antibodies. b. Representative immunofluorescence images showing cellular RAP80 colocalization with the viral proteins ICP0, ICP4, and ICP8 in HeLa cells. Images were captured at 3 h post-infection with HSV-1 (MOI=1). Quantified RAP80 (red) and viral protein (green) fluorescence intensity values at colocalization sites were determined using ImageJ software. c. RAP80 knockdown (KD) effects on viral TK expression were assessed in HeLa cells with depleted RAP80 at 3 h or 20 h post-infection with HSV-1 (MOI=1). d. Specific RAP80 binding sites in the HSV-1 genome were investigated by ChIP-seq using ChIP DNA extracted from HeLa cells with a RAP80 antibody at 3 h post HSV-1 infection (MOI=1). Specific HSV-1 genomic regions, where ChIP-sequencing peaks aligned, are shown in a comprehensive plot. e. 3D-SIM was used to visualize RAP80 colocalization (red) with ICP4 (green) in HeLa cells infected with HSV-1 (MOI=1) for 3 h. f. RAP80 KD effects on RNA polymerase II recruitment to viral gene promoters were evaluated in HeLa cells by ChIP assays using the RNA polymerase II S2P antibody. g. Representative immunofluorescence images showing ICP4 in WT and RAP80 KD HeLa cells following infection with HSV-1 (MOI=1) for 3 h (left). ICP4 droplet diameters were measured in Imariz software (right). The graph represents data from three independent experiments and counts represent 50–100 infected cells. h, i . Immunofluorescence images showing RAP80 -depleted HeLa cells re-expressing WT RAP80 or its mutant ( 2AS or 3KR ), which were infected with HSV-1 (MOI=1) for 3 h. Cells were stained with DAPI and ICP4 and RAP80-specific antibodies. (h) ICP4 droplet diameters and colocalization between different RAP80 and ICP4 forms were measured (i). j. RAP80 effects on TK expression were evaluated in RAP80 -depleted HeLa cells plus reintroduced WT RAP80 or mutants ( 2AS or 3KR ). Cells were infected with HSV-1 (MOI=1) for 3 h and qRT-PCR assays performed to examine TK expression. k. RNA polymerase II recruitment to viral gene promoters was assessed in HeLa cells expressing WT RAP80 or mutants ( 2AS or 3KR ) in ChIP assays using a specific RNA polymerase II S2P antibody. l. The model shows multivalent interactions between RAP80 and ICP4 in phase separation formation (viral pre-replication foci). After HSV-1 infection, RAP80 binds to the viral transcription factor ICP4 and the viral genome through its UIM domain, driving phase separation formation. Data in panels c, f, g, i-k are presented as the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Journal: bioRxiv

    Article Title: HSV-1 orchestrates host RAP80 ubiquitination by ICP0 and UL36USP to promote viral survival

    doi: 10.1101/2025.06.10.658793

    Figure Lengend Snippet: a. Endogenous RAP80 expression profiles across various post-HSV-1 infection stages were evaluated in HeLa cells exposed to HSV-1 at a multiplicity of infection (MOI) = 1. Cells were harvested at different time points post-infection, and RAP80 and ICP0 protein levels examined by immunoblotting with specific antibodies. b. Representative immunofluorescence images showing cellular RAP80 colocalization with the viral proteins ICP0, ICP4, and ICP8 in HeLa cells. Images were captured at 3 h post-infection with HSV-1 (MOI=1). Quantified RAP80 (red) and viral protein (green) fluorescence intensity values at colocalization sites were determined using ImageJ software. c. RAP80 knockdown (KD) effects on viral TK expression were assessed in HeLa cells with depleted RAP80 at 3 h or 20 h post-infection with HSV-1 (MOI=1). d. Specific RAP80 binding sites in the HSV-1 genome were investigated by ChIP-seq using ChIP DNA extracted from HeLa cells with a RAP80 antibody at 3 h post HSV-1 infection (MOI=1). Specific HSV-1 genomic regions, where ChIP-sequencing peaks aligned, are shown in a comprehensive plot. e. 3D-SIM was used to visualize RAP80 colocalization (red) with ICP4 (green) in HeLa cells infected with HSV-1 (MOI=1) for 3 h. f. RAP80 KD effects on RNA polymerase II recruitment to viral gene promoters were evaluated in HeLa cells by ChIP assays using the RNA polymerase II S2P antibody. g. Representative immunofluorescence images showing ICP4 in WT and RAP80 KD HeLa cells following infection with HSV-1 (MOI=1) for 3 h (left). ICP4 droplet diameters were measured in Imariz software (right). The graph represents data from three independent experiments and counts represent 50–100 infected cells. h, i . Immunofluorescence images showing RAP80 -depleted HeLa cells re-expressing WT RAP80 or its mutant ( 2AS or 3KR ), which were infected with HSV-1 (MOI=1) for 3 h. Cells were stained with DAPI and ICP4 and RAP80-specific antibodies. (h) ICP4 droplet diameters and colocalization between different RAP80 and ICP4 forms were measured (i). j. RAP80 effects on TK expression were evaluated in RAP80 -depleted HeLa cells plus reintroduced WT RAP80 or mutants ( 2AS or 3KR ). Cells were infected with HSV-1 (MOI=1) for 3 h and qRT-PCR assays performed to examine TK expression. k. RNA polymerase II recruitment to viral gene promoters was assessed in HeLa cells expressing WT RAP80 or mutants ( 2AS or 3KR ) in ChIP assays using a specific RNA polymerase II S2P antibody. l. The model shows multivalent interactions between RAP80 and ICP4 in phase separation formation (viral pre-replication foci). After HSV-1 infection, RAP80 binds to the viral transcription factor ICP4 and the viral genome through its UIM domain, driving phase separation formation. Data in panels c, f, g, i-k are presented as the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Article Snippet: The following antibodies were used: Anti-Flag (M2, F3165, Sigma), anti-HA (HA-7, H9658, Sigma), anti-Myc (M047-3, MBL), anti-His (D291-3x, L), anti-β-actin (PM053, Abclonal), anti-RAP80 (A7244, Abclonal), anti-ICP0 (sc-53070, Santa Cruz), anti-ICP4 (sc-69809, Santa Cruz), anti-ICP8 (sc-53329, Santa Cruz), anti-RNA polymerase II S5P (ab5408, Abcam), anti-cGAS (sc-515777, Santa Cruz), and anti-CENP-A (A15995, Abclonal).

    Techniques: Expressing, Infection, Western Blot, Immunofluorescence, Fluorescence, Software, Knockdown, Binding Assay, ChIP-sequencing, Mutagenesis, Staining, Quantitative RT-PCR

    a. ICP0 enzyme effects on the establishment of the HSV-1 replication compartment were evaluated in HeLa cells by immunofluorescence microscopy. Cells were infected with either WT HSV-1 or an ICP0-deficient mutant strain ( ΔICP0 HSV-1 ) (MOI=1) and incubated for 6 h. Subsequently, cells were stained with antibodies against ICP4 and RAP80. Representative immunofluorescence images are shown. b. ICP0 enzyme deficiency effects on RAP80 depletion-promoted TK expression were explored in HeLa cells infected with either WT HSV-1 or ΔICP0 HSV-1 (MOI=1) for 6 h. qRT-PCR was performed in triplicate to evaluate TK expression. c. Interactions between ICP0 and RAP80 mutants were examined using co-IP assays in HEK293T cells. Cells were co-transfected with Flag-tagged ICP0 and either Myc-tagged WT RAP80 or its mutants ( 2AS or 3KR ), and co-IP assays performed using indicated antibodies. d. Crystallographic analysis shows a significant binding pattern alteration in RAP80 following ubiquitination of its 3K sites (K75, 90, and 112). Post-ubiquitination, the RAP80 UIM domain binds to its own ubiquitination chains, attenuating its binding to ICP0. e. RAP80 ubiquitination effects on its association with viral proteins were examined in HEK293T cells by co-IP assays. Cells were co-transfected with Myc-RAP80 and either WT RAP80 or mutant variants ( 2AS and 3KR ) along with HA-tagged ubiquitin, and subsequently infected with HSV-1 for 6 h (MOI=1) before harvest. Cell lysates were subjected to IP with an anti-Flag antibody and analyzed by western blotting using anti-Flag, anti-ICP0, and anti-ICP4 antibodies. f. RAP80 and mutant effects on HSV-1 replication centers were observed by IF in HeLa cells infected with HSV-1 (MOI=1) for 6 h. g. The impact of UL36USP on ICP0-catalyzed ubiquitination was examined in HEK293T cells. Cells were co-transfected with Myc-tagged ICP0, HA-tagged ubiquitin, and Flag-tagged UL36USP, with cell lysates immunoprecipitated using an anti-Myc antibody, and analyzed by western blotting using anti-Myc and anti-HA antibodies. h. UL36USP effects on the interaction between RAP80 and ubiquitinated ICP0 were assessed in in vitro pull-down assays. Flag-tagged RAP80 immunoprecipitated from HEK293T cells was incubated in vitro with purified ubiquitinated ICP0 in the presence/absence of UL36USP protein, and then western blotting performed with indicated antibodies. i. The model shows the interplay of ubiquitination on RAP80 by ICP0 and UL36USP at different post-HSV-1 infection stages. During mid-stage, ICP0 catalyzes the K48- and K63-type ubiquitination of RAP80, resulting in RAP80 degradation and the dissolution of phase separation. In late infection stages, UL36USP deubiquitinates RAP80, thereby stabilizing RAP80 and facilitating viral propagation. Data in panels b and f are presented as the mean ± standard error of the mean from three independent experiments. **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Journal: bioRxiv

    Article Title: HSV-1 orchestrates host RAP80 ubiquitination by ICP0 and UL36USP to promote viral survival

    doi: 10.1101/2025.06.10.658793

    Figure Lengend Snippet: a. ICP0 enzyme effects on the establishment of the HSV-1 replication compartment were evaluated in HeLa cells by immunofluorescence microscopy. Cells were infected with either WT HSV-1 or an ICP0-deficient mutant strain ( ΔICP0 HSV-1 ) (MOI=1) and incubated for 6 h. Subsequently, cells were stained with antibodies against ICP4 and RAP80. Representative immunofluorescence images are shown. b. ICP0 enzyme deficiency effects on RAP80 depletion-promoted TK expression were explored in HeLa cells infected with either WT HSV-1 or ΔICP0 HSV-1 (MOI=1) for 6 h. qRT-PCR was performed in triplicate to evaluate TK expression. c. Interactions between ICP0 and RAP80 mutants were examined using co-IP assays in HEK293T cells. Cells were co-transfected with Flag-tagged ICP0 and either Myc-tagged WT RAP80 or its mutants ( 2AS or 3KR ), and co-IP assays performed using indicated antibodies. d. Crystallographic analysis shows a significant binding pattern alteration in RAP80 following ubiquitination of its 3K sites (K75, 90, and 112). Post-ubiquitination, the RAP80 UIM domain binds to its own ubiquitination chains, attenuating its binding to ICP0. e. RAP80 ubiquitination effects on its association with viral proteins were examined in HEK293T cells by co-IP assays. Cells were co-transfected with Myc-RAP80 and either WT RAP80 or mutant variants ( 2AS and 3KR ) along with HA-tagged ubiquitin, and subsequently infected with HSV-1 for 6 h (MOI=1) before harvest. Cell lysates were subjected to IP with an anti-Flag antibody and analyzed by western blotting using anti-Flag, anti-ICP0, and anti-ICP4 antibodies. f. RAP80 and mutant effects on HSV-1 replication centers were observed by IF in HeLa cells infected with HSV-1 (MOI=1) for 6 h. g. The impact of UL36USP on ICP0-catalyzed ubiquitination was examined in HEK293T cells. Cells were co-transfected with Myc-tagged ICP0, HA-tagged ubiquitin, and Flag-tagged UL36USP, with cell lysates immunoprecipitated using an anti-Myc antibody, and analyzed by western blotting using anti-Myc and anti-HA antibodies. h. UL36USP effects on the interaction between RAP80 and ubiquitinated ICP0 were assessed in in vitro pull-down assays. Flag-tagged RAP80 immunoprecipitated from HEK293T cells was incubated in vitro with purified ubiquitinated ICP0 in the presence/absence of UL36USP protein, and then western blotting performed with indicated antibodies. i. The model shows the interplay of ubiquitination on RAP80 by ICP0 and UL36USP at different post-HSV-1 infection stages. During mid-stage, ICP0 catalyzes the K48- and K63-type ubiquitination of RAP80, resulting in RAP80 degradation and the dissolution of phase separation. In late infection stages, UL36USP deubiquitinates RAP80, thereby stabilizing RAP80 and facilitating viral propagation. Data in panels b and f are presented as the mean ± standard error of the mean from three independent experiments. **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Article Snippet: The following antibodies were used: Anti-Flag (M2, F3165, Sigma), anti-HA (HA-7, H9658, Sigma), anti-Myc (M047-3, MBL), anti-His (D291-3x, L), anti-β-actin (PM053, Abclonal), anti-RAP80 (A7244, Abclonal), anti-ICP0 (sc-53070, Santa Cruz), anti-ICP4 (sc-69809, Santa Cruz), anti-ICP8 (sc-53329, Santa Cruz), anti-RNA polymerase II S5P (ab5408, Abcam), anti-cGAS (sc-515777, Santa Cruz), and anti-CENP-A (A15995, Abclonal).

    Techniques: Immunofluorescence, Microscopy, Infection, Mutagenesis, Incubation, Staining, Expressing, Quantitative RT-PCR, Co-Immunoprecipitation Assay, Transfection, Binding Assay, Ubiquitin Proteomics, Western Blot, Immunoprecipitation, In Vitro, Purification, Dissolution

    a. RAP80 depletion effects on HSV-1 replication during late infection stages were monitored using plaque assays in HeLa cells with RAP80 knockdown (KD) at 20 h post HSV-1 infection (MOI=1). WT HeLa cells under identical conditions served as controls. b. WT HeLa and RAP80 KD cells were infected with HSV-1-GFP for 20 h, after which, viral GFP mean fluorescence intensity (MFI) was quantified using flow cytometry to determine RAP80 depletion effects on HSV-1 amplification. c. WT and RAP80 KD HeLa cells were infected with HSV-1 (MOI=1) for 20 h, after which RAP80 effects on apoptosis were evaluated by Annexin V and propidium iodide (PI) staining. WT HeLa cells under identical condition served as controls. d. RAP80 KD effects on viral replication were measured by infecting WT and RAP80 KD HeLa cells with HSV-1 (MOI=1). At 20 h post-infection, supernatants were harvested and incubated with BHK cells and finally subjected to plaque assays to measure HSV-1 replication. e. The impact of the apoptosis inhibitor Z-VAD on HSV-1 amplification in RAP80 KD HeLa cells was examined. WT and RAP80 KD cells were pretreated with 5 μM Z-VAD or control conditions before infection with HSV-1. Viral replication was quantified using plaque assays. f. WT and RAP80 KD HeLa cells were exposed to a Z-VAD concentration gradient (5–50 μM), after which plaque assays were conducted to assess varying Z-VAD concentration effects on HSV-1 replication efficiency. g. Gene enrichment analysis was conducted using RNA sequencing data to identify differentially expressed genes in RAP80 KD HeLa cells infected with HSV-1 at 20 h post-infection (MOI=1). h. WT and RAP80 KD HeLa cells were treated with 5 μM of RU.521 (cGAS inhibitor) prior to infection with HSV-1. HSV-1 replication was then measured using plaque assays. i. RAP80 KD effects on the interaction between cGAS and R-loops was assessed using PLA in WT and RAP80 KD HeLa cells. After infection with HSV-1 (MOI=1) for 20 h, PLA was performed to investigate in situ interactions between cGAS and R-loops (using the S9.6 antibody). j. PLA was performed to investigate RNase H effects on RAP80 depletion-promoted R-loops in HeLa cells. WT and RAP80 KD HeLa cells with/without overexpressed RNase H were infected with HSV-1 (MOI=1) for 20 h, and PLA conducted to examine interactions between cGAS and R-loops (S9.6 antibody). k, l. WT and RAP80 KD HeLa cells with/without overexpressed RNase H were infected with HSV-1 (MOI=1) for 20 h, after which flow cytometry was conducted to examine apoptosis levels (k), and plaque assays performed to quantify viral replication (l). m. The model shows disrupted cellular homeostasis by HSV-1 following RAP80 KD. RAP80 depletion leads to R-loop accumulation and transmission to the cytoplasm. In the cytoplasm, R-loops are recognized by cGAS, activating innate immunity pathways and inducing apoptosis, which attenuates the viral lytic cycle. Data are presented as the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Journal: bioRxiv

    Article Title: HSV-1 orchestrates host RAP80 ubiquitination by ICP0 and UL36USP to promote viral survival

    doi: 10.1101/2025.06.10.658793

    Figure Lengend Snippet: a. RAP80 depletion effects on HSV-1 replication during late infection stages were monitored using plaque assays in HeLa cells with RAP80 knockdown (KD) at 20 h post HSV-1 infection (MOI=1). WT HeLa cells under identical conditions served as controls. b. WT HeLa and RAP80 KD cells were infected with HSV-1-GFP for 20 h, after which, viral GFP mean fluorescence intensity (MFI) was quantified using flow cytometry to determine RAP80 depletion effects on HSV-1 amplification. c. WT and RAP80 KD HeLa cells were infected with HSV-1 (MOI=1) for 20 h, after which RAP80 effects on apoptosis were evaluated by Annexin V and propidium iodide (PI) staining. WT HeLa cells under identical condition served as controls. d. RAP80 KD effects on viral replication were measured by infecting WT and RAP80 KD HeLa cells with HSV-1 (MOI=1). At 20 h post-infection, supernatants were harvested and incubated with BHK cells and finally subjected to plaque assays to measure HSV-1 replication. e. The impact of the apoptosis inhibitor Z-VAD on HSV-1 amplification in RAP80 KD HeLa cells was examined. WT and RAP80 KD cells were pretreated with 5 μM Z-VAD or control conditions before infection with HSV-1. Viral replication was quantified using plaque assays. f. WT and RAP80 KD HeLa cells were exposed to a Z-VAD concentration gradient (5–50 μM), after which plaque assays were conducted to assess varying Z-VAD concentration effects on HSV-1 replication efficiency. g. Gene enrichment analysis was conducted using RNA sequencing data to identify differentially expressed genes in RAP80 KD HeLa cells infected with HSV-1 at 20 h post-infection (MOI=1). h. WT and RAP80 KD HeLa cells were treated with 5 μM of RU.521 (cGAS inhibitor) prior to infection with HSV-1. HSV-1 replication was then measured using plaque assays. i. RAP80 KD effects on the interaction between cGAS and R-loops was assessed using PLA in WT and RAP80 KD HeLa cells. After infection with HSV-1 (MOI=1) for 20 h, PLA was performed to investigate in situ interactions between cGAS and R-loops (using the S9.6 antibody). j. PLA was performed to investigate RNase H effects on RAP80 depletion-promoted R-loops in HeLa cells. WT and RAP80 KD HeLa cells with/without overexpressed RNase H were infected with HSV-1 (MOI=1) for 20 h, and PLA conducted to examine interactions between cGAS and R-loops (S9.6 antibody). k, l. WT and RAP80 KD HeLa cells with/without overexpressed RNase H were infected with HSV-1 (MOI=1) for 20 h, after which flow cytometry was conducted to examine apoptosis levels (k), and plaque assays performed to quantify viral replication (l). m. The model shows disrupted cellular homeostasis by HSV-1 following RAP80 KD. RAP80 depletion leads to R-loop accumulation and transmission to the cytoplasm. In the cytoplasm, R-loops are recognized by cGAS, activating innate immunity pathways and inducing apoptosis, which attenuates the viral lytic cycle. Data are presented as the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Data analysis was conducted using ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Article Snippet: The following antibodies were used: Anti-Flag (M2, F3165, Sigma), anti-HA (HA-7, H9658, Sigma), anti-Myc (M047-3, MBL), anti-His (D291-3x, L), anti-β-actin (PM053, Abclonal), anti-RAP80 (A7244, Abclonal), anti-ICP0 (sc-53070, Santa Cruz), anti-ICP4 (sc-69809, Santa Cruz), anti-ICP8 (sc-53329, Santa Cruz), anti-RNA polymerase II S5P (ab5408, Abcam), anti-cGAS (sc-515777, Santa Cruz), and anti-CENP-A (A15995, Abclonal).

    Techniques: Infection, Knockdown, Fluorescence, Flow Cytometry, Amplification, Staining, Incubation, Control, Concentration Assay, RNA Sequencing, In Situ, Transmission Assay

    a. ChIP-seq analysis was performed using an RAP80-specific antibody in HeLa cells, with ChIP DNA collected at 3 h and 20 h post-infection (MOI=1). Filtered peaks from ChIP-seq data were then annotated and analyzed for RAP80 binding patterns. b. R-loop accumulation at centromeres was evaluated in WT and RAP80 KD HeLa cells infected with HSV-1 (MOI=1) for 20 h post-infection, in the presence/absence of RNase H, using CUT-tag– quantitative PCR (CUT-tag-qPCR) assays with an anti-S9.6 antibody to analyze the binding profiles of various centromeric DNA, Cen1-like, Cen9, and mbox. c–j. Protein recruitment, including BRCA1(c), γH2AX (d); RAD51 (e), RAD52 (f) to centromeres, was evaluated in WT and RAP80 KD HeLa cells infected with HSV-1 (MOI=1) for 20 h. CUT-tag-qPCR assays were used to analyze protein binding profiles to different genes, including Cen1-like, Cen9, and mbox . g . Representative images showing chromosome spreads from HeLa cells with WT or depleted RAP80 in RNase H overexpressing cells infected with HSV-1 20 h post infection (MOI=1). White arrows indicate centromeric breaks. h. The model highlights a pivotal role for RAP80 in maintaining centromere stability via degraded R-loops. RAP80 degrades R-loops by recruiting BRCA1 and nucleases. RAP80 knockdown (KD) leads to R-loop accumulation and DNA damage at centromeres. This accumulation not only threatens centromere structural integrity but also disrupts finely tuned DNA damage repair processes. RAP80 plays a role in pathway selection for centromeric DSB repair. In its absence, DSBs are repaired by the RAD52-mediated pathway, and RAD51 is excluded from centromeric DSBs. The RAD52-mediated repair pathway results in uncontrolled homologous recombination, which is coupled to R-loop and DSB accumulation, and also prevents CENP-A deposition and promotes transcription. These combined effects lead to centromeric instability. Data in panels b-g are the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Journal: bioRxiv

    Article Title: HSV-1 orchestrates host RAP80 ubiquitination by ICP0 and UL36USP to promote viral survival

    doi: 10.1101/2025.06.10.658793

    Figure Lengend Snippet: a. ChIP-seq analysis was performed using an RAP80-specific antibody in HeLa cells, with ChIP DNA collected at 3 h and 20 h post-infection (MOI=1). Filtered peaks from ChIP-seq data were then annotated and analyzed for RAP80 binding patterns. b. R-loop accumulation at centromeres was evaluated in WT and RAP80 KD HeLa cells infected with HSV-1 (MOI=1) for 20 h post-infection, in the presence/absence of RNase H, using CUT-tag– quantitative PCR (CUT-tag-qPCR) assays with an anti-S9.6 antibody to analyze the binding profiles of various centromeric DNA, Cen1-like, Cen9, and mbox. c–j. Protein recruitment, including BRCA1(c), γH2AX (d); RAD51 (e), RAD52 (f) to centromeres, was evaluated in WT and RAP80 KD HeLa cells infected with HSV-1 (MOI=1) for 20 h. CUT-tag-qPCR assays were used to analyze protein binding profiles to different genes, including Cen1-like, Cen9, and mbox . g . Representative images showing chromosome spreads from HeLa cells with WT or depleted RAP80 in RNase H overexpressing cells infected with HSV-1 20 h post infection (MOI=1). White arrows indicate centromeric breaks. h. The model highlights a pivotal role for RAP80 in maintaining centromere stability via degraded R-loops. RAP80 degrades R-loops by recruiting BRCA1 and nucleases. RAP80 knockdown (KD) leads to R-loop accumulation and DNA damage at centromeres. This accumulation not only threatens centromere structural integrity but also disrupts finely tuned DNA damage repair processes. RAP80 plays a role in pathway selection for centromeric DSB repair. In its absence, DSBs are repaired by the RAD52-mediated pathway, and RAD51 is excluded from centromeric DSBs. The RAD52-mediated repair pathway results in uncontrolled homologous recombination, which is coupled to R-loop and DSB accumulation, and also prevents CENP-A deposition and promotes transcription. These combined effects lead to centromeric instability. Data in panels b-g are the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. Scale bars, 5 μm.

    Article Snippet: The following antibodies were used: Anti-Flag (M2, F3165, Sigma), anti-HA (HA-7, H9658, Sigma), anti-Myc (M047-3, MBL), anti-His (D291-3x, L), anti-β-actin (PM053, Abclonal), anti-RAP80 (A7244, Abclonal), anti-ICP0 (sc-53070, Santa Cruz), anti-ICP4 (sc-69809, Santa Cruz), anti-ICP8 (sc-53329, Santa Cruz), anti-RNA polymerase II S5P (ab5408, Abcam), anti-cGAS (sc-515777, Santa Cruz), and anti-CENP-A (A15995, Abclonal).

    Techniques: ChIP-sequencing, Infection, Binding Assay, Real-time Polymerase Chain Reaction, Protein Binding, Knockdown, Selection, Homologous Recombination

    a. Interactions between HSV-1 and host chromosome 1 (chr.1) near the centromere region. Tracks from the top to the bottom are (1–2) RAP80 enrichment signals in HeLa cells from ChIP-seq data at 3 h (1) and 20 h (2) post-infection. (5–6) Contacts between each 50 kb genomic bin and the HSV-1 genome in WT-HeLa cells are shown at 6 h, 9 h, 12 h, 18 h, and 24 h post-infection. Contacts without mapping quality filters are used. The centromere region is salmon-colored. b. The odds ratio for interaction enrichment between HSV-1 and the host genome in the centromere region. An odds ratio of 1 indicates no HSV-1 preference for the centromere region when compared to other regions. A ratio > 1 indicates enrichment in the centromere region, while a ratio < 1 indicates a reduction in that region. Data measured at 6 h, 9 h, 12 h, 15 h, 18 h, and 24 h post-infection are presented. c. Similar to a , but Hi-C tracks display data from RAP80 knockdown (KD) HeLa cells. d. CUT-tag-qPCR on RNA polymerase II was performed at different centromeric regions in HeLa cells infected with HSV-1 for 20 h (MOI=1). e. RAP80 KD and WT HeLa cells, as well as HeLa cells stably overexpressing RNase H, were infected with HSV-1. Samples were harvested at 20 h post-infection to analyze cenRNA transcripts using RT-qPCR. Data in panels d, e are the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. f. Similar to a , but Hi-C track data come from the following 24 h post-infection cells: RAP80 KD HeLa cells overexpressing RNase H, WT HeLa cells overexpressing RNase, RAP80 KD HeLa cells, and WT HeLa cells. g. The model highlights multifaceted roles of RAP80 in regulating the process of Herpes simplex virus 1 life cycle. RAP80 inhibits HSV-1 transcription in early post-invasion stages by interacting with the viral genome to hinder ICP4 binding to transcription factors. This interaction, mediated by phase separation influenced by multivalent interactions between RAP80’s UIM domain and ICP0/ICP4, is crucial for transcription inhibition. As infection progresses to mid-stages, phase separation dissipates. ICP0 targets RAP80 for proteasomal degradation, disrupting the RAP80-ICP0/ICP4 interaction, dissolving phase separation and facilitating the formation of virus replication compartments, which are essential for viral propagation. In late infection stages, a pivotal change occurs as RAP80 is deubiquitinated by UL36USP, allowing it to play critical roles preserving cellular homeostasis and promoting HSV-1 survival by modulating the R-loop-cGAS-apoptosis axis. This comprehensive analysis of RAP80’s multifaceted roles underscores the dynamic interplay between viral and host factors during HSV-1 infection

    Journal: bioRxiv

    Article Title: HSV-1 orchestrates host RAP80 ubiquitination by ICP0 and UL36USP to promote viral survival

    doi: 10.1101/2025.06.10.658793

    Figure Lengend Snippet: a. Interactions between HSV-1 and host chromosome 1 (chr.1) near the centromere region. Tracks from the top to the bottom are (1–2) RAP80 enrichment signals in HeLa cells from ChIP-seq data at 3 h (1) and 20 h (2) post-infection. (5–6) Contacts between each 50 kb genomic bin and the HSV-1 genome in WT-HeLa cells are shown at 6 h, 9 h, 12 h, 18 h, and 24 h post-infection. Contacts without mapping quality filters are used. The centromere region is salmon-colored. b. The odds ratio for interaction enrichment between HSV-1 and the host genome in the centromere region. An odds ratio of 1 indicates no HSV-1 preference for the centromere region when compared to other regions. A ratio > 1 indicates enrichment in the centromere region, while a ratio < 1 indicates a reduction in that region. Data measured at 6 h, 9 h, 12 h, 15 h, 18 h, and 24 h post-infection are presented. c. Similar to a , but Hi-C tracks display data from RAP80 knockdown (KD) HeLa cells. d. CUT-tag-qPCR on RNA polymerase II was performed at different centromeric regions in HeLa cells infected with HSV-1 for 20 h (MOI=1). e. RAP80 KD and WT HeLa cells, as well as HeLa cells stably overexpressing RNase H, were infected with HSV-1. Samples were harvested at 20 h post-infection to analyze cenRNA transcripts using RT-qPCR. Data in panels d, e are the mean ± standard error of the mean from three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. Ordinary one-way and two-way analysis of variance (ANOVA) and Dunnett’s multiple comparisons tests. Exact P values are provided in source data. f. Similar to a , but Hi-C track data come from the following 24 h post-infection cells: RAP80 KD HeLa cells overexpressing RNase H, WT HeLa cells overexpressing RNase, RAP80 KD HeLa cells, and WT HeLa cells. g. The model highlights multifaceted roles of RAP80 in regulating the process of Herpes simplex virus 1 life cycle. RAP80 inhibits HSV-1 transcription in early post-invasion stages by interacting with the viral genome to hinder ICP4 binding to transcription factors. This interaction, mediated by phase separation influenced by multivalent interactions between RAP80’s UIM domain and ICP0/ICP4, is crucial for transcription inhibition. As infection progresses to mid-stages, phase separation dissipates. ICP0 targets RAP80 for proteasomal degradation, disrupting the RAP80-ICP0/ICP4 interaction, dissolving phase separation and facilitating the formation of virus replication compartments, which are essential for viral propagation. In late infection stages, a pivotal change occurs as RAP80 is deubiquitinated by UL36USP, allowing it to play critical roles preserving cellular homeostasis and promoting HSV-1 survival by modulating the R-loop-cGAS-apoptosis axis. This comprehensive analysis of RAP80’s multifaceted roles underscores the dynamic interplay between viral and host factors during HSV-1 infection

    Article Snippet: The following antibodies were used: Anti-Flag (M2, F3165, Sigma), anti-HA (HA-7, H9658, Sigma), anti-Myc (M047-3, MBL), anti-His (D291-3x, L), anti-β-actin (PM053, Abclonal), anti-RAP80 (A7244, Abclonal), anti-ICP0 (sc-53070, Santa Cruz), anti-ICP4 (sc-69809, Santa Cruz), anti-ICP8 (sc-53329, Santa Cruz), anti-RNA polymerase II S5P (ab5408, Abcam), anti-cGAS (sc-515777, Santa Cruz), and anti-CENP-A (A15995, Abclonal).

    Techniques: ChIP-sequencing, Infection, Hi-C, Knockdown, Stable Transfection, Quantitative RT-PCR, Virus, Binding Assay, Inhibition, Preserving

    PKMYT1-induced NPM1 S260 phosphorylation promotes efficient DSB repair. a Western blot analysis of the expression of PKMYT1, phosphorylated-NPM1 S260, and phosphorylated-NPM1 T199 in OS cells after being treated with various concentrations of DDP. b – d Western blot analysis of the effect of DDP and IR on NPM1 S260 phosphorylation after PKMYT1 knockdown or inhibition with RP6306. e Western blot analysis of the impact of DDP and IR on NPM1 S260 phosphorylation following the overexpression of NPM1 S260 dephosphorylation mutant plasmid. f After transfection as indicated siRNAs for 48 h, HEK293T cells were collected and subjected to co-immunoprecipitation experiments followed by western blot analysis. g HEK293T cells were transfected with indicated siRNAs for 48 h and treated with or without cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. h HEK293T cells were treated with or without RP6306 (2 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. i HEK293T cells were treated with or without RP6306 (2 μM) and cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. j HEK293T cells were transfected with indicated plasmids for 24 h and treated with or without cisplatin (1 μM) before harvesting the cells for co-immunoprecipitation and Western blot. k – l Immunofluorescence analysis of the effect of NPM1 S260 phosphorylation on IR-induced BRCA1 foci. NPM1 knockout U2OS cells were rescued with either wild-type NPM1, NPM1 S260A mutant and NPM1 S260D mutant, with or without IR (10 Gy) treatment. Representative images are shown in k , and the number of BRCA1 foci per group was calculated in l. Approximately 100 cells were counted per group. Data are expressed as the mean ± SEM from three biological replicates. Statistical analysis was performed using Student’s t test, p value as indicated. Scale bar, 10 μm. m – n Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in m, and the number of BRCA1 foci per group was calculated in n, p value as indicated. Scale bar, 10 μm. o – p NPM1 knockout U2OS cells were rescued with indicated plasmids for 24 h, and immunofluorescence analysis of cells exposed to 10 Gy IR and recovered for 1 h. Representative immunofluorescence images were shown in o , and the number of RAD51 foci per group was shown in p , p value as indicated. Scale bar, 10 μm. q – r Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( q ), and the number of RAD51 foci per group was calculated in r . Scale bar, 10 μm. s , t Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( s ), and the number of RAP80 foci per group was calculated in t , p value as indicated. Scale bar, 10 μm. u HR assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with BRCA1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts. P value as indicated. v NHEJ assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with 53BP1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts, p value as indicated

    Journal: Signal Transduction and Targeted Therapy

    Article Title: PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma

    doi: 10.1038/s41392-025-02250-7

    Figure Lengend Snippet: PKMYT1-induced NPM1 S260 phosphorylation promotes efficient DSB repair. a Western blot analysis of the expression of PKMYT1, phosphorylated-NPM1 S260, and phosphorylated-NPM1 T199 in OS cells after being treated with various concentrations of DDP. b – d Western blot analysis of the effect of DDP and IR on NPM1 S260 phosphorylation after PKMYT1 knockdown or inhibition with RP6306. e Western blot analysis of the impact of DDP and IR on NPM1 S260 phosphorylation following the overexpression of NPM1 S260 dephosphorylation mutant plasmid. f After transfection as indicated siRNAs for 48 h, HEK293T cells were collected and subjected to co-immunoprecipitation experiments followed by western blot analysis. g HEK293T cells were transfected with indicated siRNAs for 48 h and treated with or without cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. h HEK293T cells were treated with or without RP6306 (2 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. i HEK293T cells were treated with or without RP6306 (2 μM) and cisplatin (1 μM) for 24 h before harvesting the cells for co-immunoprecipitation and Western blot. j HEK293T cells were transfected with indicated plasmids for 24 h and treated with or without cisplatin (1 μM) before harvesting the cells for co-immunoprecipitation and Western blot. k – l Immunofluorescence analysis of the effect of NPM1 S260 phosphorylation on IR-induced BRCA1 foci. NPM1 knockout U2OS cells were rescued with either wild-type NPM1, NPM1 S260A mutant and NPM1 S260D mutant, with or without IR (10 Gy) treatment. Representative images are shown in k , and the number of BRCA1 foci per group was calculated in l. Approximately 100 cells were counted per group. Data are expressed as the mean ± SEM from three biological replicates. Statistical analysis was performed using Student’s t test, p value as indicated. Scale bar, 10 μm. m – n Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in m, and the number of BRCA1 foci per group was calculated in n, p value as indicated. Scale bar, 10 μm. o – p NPM1 knockout U2OS cells were rescued with indicated plasmids for 24 h, and immunofluorescence analysis of cells exposed to 10 Gy IR and recovered for 1 h. Representative immunofluorescence images were shown in o , and the number of RAD51 foci per group was shown in p , p value as indicated. Scale bar, 10 μm. q – r Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout U2OS cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( q ), and the number of RAD51 foci per group was calculated in r . Scale bar, 10 μm. s , t Immunofluorescence analysis of PKMYT1 wild-type and PKMYT1 knockout cells with or without IR (10 Gy) treatment. Representative immunofluorescence images were shown in ( s ), and the number of RAP80 foci per group was calculated in t , p value as indicated. Scale bar, 10 μm. u HR assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with BRCA1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts. P value as indicated. v NHEJ assay in PKMYT1 wild-type and PKMYT1 knockout HEK293T cells, with 53BP1 knockout as control. Data are presented as the mean ± SEM from three replicates. Each group included over 1000 cell counts, p value as indicated

    Article Snippet: The antibodies used in this study are as follows: GAPDH (#60004-1-Ig, Proteintech, 1:10,000 dilution), PKMYT1 (#4282S, Cell Signaling Technology, 1:1,000 dilution), NPM1 (#60096-1-Ig, Proteintech, 1:5,000 dilution), p-NPM1 T199 (#AF3111, Affnity, 1:1000 dilution), p-NPM1 S260 (#TP50488, HUABIO, 1:3000 dilution), p-Histone H2A.X S139 (# P40705 , ProMab Biotechnologies Inc., China, 1:1000 dilution), RAP80 (#13642-1-AP, Proteintech, 1:1000 dilution), BRCA1 (#22362-1-AP, Proteintech, 1:1000 dilution), RAD51(#14961-1-AP, Proteintech, China, 1:2000 dilution), anti-HA (#AB0004, Abways, China, 1:2000 dilution), β-actin (A00730, Genscript Biotech, 1:1000 dilution), Phosphoserine/threonine/tyrosine (#11995 R, Yajikit, 1:100 dilution), HRP conjugated goat-anti-mouse antibody (#SA00001-1, Proteintech, 1:10,000 dilution) and HRP conjugated goat-anti-rabbit antibody (#511203, zen-bioscience, 1:5000 dilution).

    Techniques: Phospho-proteomics, Western Blot, Expressing, Knockdown, Inhibition, Over Expression, De-Phosphorylation Assay, Mutagenesis, Plasmid Preparation, Transfection, Immunoprecipitation, Immunofluorescence, Knock-Out, Control, NHEJ Assay